Evidence map›Paper›PMID 34118017›Full record

ArticleEndocrine2021

Low reproducibility of equivocal categories of the Bethesda System for Reporting Thyroid Cytology makes the associated risk of malignancy specific to the diagnostic center.

Dorota Słowińska-Klencka, Mariusz Klencki, Joanna Duda-Szymańska, Jarosław Szwalski, Bożena Popowicz

Abstract read
In one paragraph

Article in Endocrine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Dorota Słowińska-KlenckaDepartment of Morphometry of Endocrine Glands, Chair of Endocrinology, Medical University of Lodz, 251 Pomorska Str, 92-213, Lodz, Poland. dsk@tyreo.umed.lodz.pl.ORCID 0000-0002-5617-0418
Mariusz KlenckiDepartment of Morphometry of Endocrine Glands, Chair of Endocrinology, Medical University of Lodz, 251 Pomorska Str, 92-213, Lodz, Poland.
Joanna Duda-SzymańskaDepartment of Pathomorphology, Chair of Oncology, Medical University of Lodz, 251 Pomorska Str, 92-213, Lodz, Poland.
Jarosław SzwalskiDepartment of Morphometry of Endocrine Glands, Chair of Endocrinology, Medical University of Lodz, 251 Pomorska Str, 92-213, Lodz, Poland.
Bożena PopowiczDepartment of Morphometry of Endocrine Glands, Chair of Endocrinology, Medical University of Lodz, 251 Pomorska Str, 92-213, Lodz, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeEquivocal categories (III, IV, V) of the Bethesda System for Reporting Thyroid Cytology (BSRTC) are characterized by high variability of the estimated risk of malignancy. The aim of the study was to analyze the reproducibility of classification of nodules into an equivocal category and the frequency of malignancy (FoM) observed in such categories.

methodsFive experienced cytopathologists from three centers (A, B, C) independently performed reclassification of smears obtained from 213 thyroid nodules with equivocal routine cytology and known results of the postoperative histopathological examination.

resultsThe interobserver agreement among all cytopathologists was poor, with a Krippendorff's alpha coefficient equaling 0.34. The intra-center agreement was higher than the inter-center (fair vs poor). Pathologists of the center A classified smears into categories II and III significantly less often and categories IV and V more often than pathologists of centers B and C. The joint FoM of nodules classified into any of categories IV-VI (regarded as an indication for surgery) was different among centers (A: 40.0%, B: 66.7%, C: 80.6%). The FoM of category III nodules with features of nuclear atypia (AUS) in center B and C was two times higher than that of other nodules of category III (FLUS), while in center A the FoM was similar.

conclusionsThe use of published data on the risk of malignancy in nodules of particular BSRTC categories without concern for the uniqueness of the diagnostic center may lead to erroneous conclusions.

Indexed as

Thyroid NeoplasmsThyroid NoduleBiopsy, Fine-NeedleHumansReproducibility of ResultsRetrospective StudiesBethesda systemCytologyFNAReproducibilityThyroid cancer

Identifiers

PMID34118017
PMCPMC8497291

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.